Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Kir3.1 activators(potassium inwardly rectifying channel subfamily J member 3 activators), Kir3.2 activators(potassium inwardly rectifying channel subfamily J member 6 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13BrN4OS |
InChIKeyHLUAZGBYPUZZBS-UHFFFAOYSA-N |
CAS Registry2397594-21-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stress Disorders, Post-Traumatic | Preclinical | US | 17 Jan 2020 |